Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mykola Zhelavskyi has a total of 51 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Filgrastim as an immunomodulatory adjunct in severe feline panleukope-nia: hematological, functional, and clinical outcomes

    by M. M. Zhelavskyi, S. P. Kernychnyi, M. O. Maryniuk, M. I. Tsvilikhovskyi, O. Ya. Dmytriv

    Feline panleukopenia (FPV) causes severe neutropenia and immunosuppression, leading to high mortality in kittens. Granulocyte colony‑stimulating factor (G‑CSF) is used to accelerate neutrophil recovery, but its effects on neutrophil functional activity in cats remain poorly characterized. Therefore, the present study aimed to evaluate the immunomodulatory effects of filgrastim (Zarzio®, Sandoz, Austria) as part of a combination treatment protocol in cats with naturally occurring FPV infection, with particular focus on (i) hematological recovery, (ii) neutrophil oxidative burst and phagocytic capacity, and (iii) clinical outcomes. Twenty‑four mixed‑breed cats (Felis catus, 2–9 months) with PCR‑confirmed FPV were randomly assigned to a control group (standard supportive therapy only, n = 12) or an experimental group (standard therapy plus filgrastim 5 μg/kg SC once daily for 5 days, n = 12). Blood was collected on days 0, 3, 5, 7, 14, and 21. Hematology (VetScan HM5, Abaxis, USA), biochemistry (VetScan V2, Abaxis, USA), spontaneous and stimulated nitroblue tetrazolium (NBT) reduction test, and clinical scores were assessed. Filgrastim significantly accelerated leukocyte and neutrophil recovery: by day 5, total leukocytes reached 8.34 ± 0.91 × 10⁹/L in the experimental group vs. 4.12 ± 0.67 × 10⁹/L in controls (P < 0.01). Importantly, the percentage of spontaneous NBT‑positive neutrophils increased from 8.1 ± 1.3 % at admission to 42.6 ± 3.8 % on day 5 in treated cats, while controls remained below 15 % (P < 0.001). Vomiting ceased 1.5 days earlier in the filgrastim group than in controls, and hospitalization duration was shorter (5.2 ± 0.4 vs. 8.7 ± 0.6 days, P < 0.01). The survival rate was 91.7 % in the filgrastim group vs. 66.7 % in the control group. No severe adverse events were recorded. Adjunctive filgrastim therapy not only restores neutrophil counts but also enhances their functional antimicrobial capacity, leading to faster clinical recovery and improved survival in FPV‑infected cats. Its use is recommended in cases of profound neutropenia (<0.5 × 10⁹/L) at diagnosis.

  • Open Access

    Clinical experience with ASD-based adjuvant therapy for wound regeneration in cats

    by M. M. Zhelavskyi, S. P. Kernychnyi, O. Ya. Dmytriv, T. V. Betlinska

    Wound healing in cats remains a clinically relevant challenge due to species-specific anatomical features, prolonged inflammatory responses, and a relatively high risk of delayed epithelialization. The present case report evaluated the clinical efficacy and systemic safety of topical application of ASD fraction 3 ointment as an adjuvant therapy for the treatment of a cervical skin wound in a cat, with particular emphasis on wound healing dynamics, inflammatory status, metabolic balance, and potential adverse effects. At the initiation of treatment (Day 1), the cat presented with an open, round wound located in the cervical region, measuring 4.75 cm in diameter. The wound surface exhibited moderate edema, hyperemia of the surrounding tissues, and serosanguineous exudation, consistent with the inflammatory phase of wound healing. Topical ASD fraction 3 ointment was applied according to the treatment protocol, and the animal was monitored through regular clinical examinations as well as serial hematological and biochemical assessments conducted on Days 1, 7, 14, and 21. By Day 7 of treatment, a marked reduction in wound size was observed, with the wound area decreasing to approximately 65–70 % of the initial value. This reduction was accompanied by a noticeable decrease in exudation, contraction of the wound margins, and formation of viable granulation tissue. By day 14, further wound contraction was recorded, with the residual wound area reduced to approximately 20–25 % of baseline, indicating active epithelialization and progression toward tissue repair. Complete clinical wound healing was achieved by Day 21, characterized by full restoration of skin integrity and the formation of a thin, elastic scar without signs of inflammation or local complications. Hematological evaluation at baseline revealed moderate leukocytosis with neutrophilia, reflecting an active localized inflammatory response. During the course of treatment, leukocyte counts and differential parameters progressively normalized, indicating effective resolution of inflammation. Biochemical analysis demonstrated transient hypoproteinemia and hypoalbuminemia at the initial stage, followed by gradual normalization during healing. Liver and renal function markers remained within physiological reference ranges throughout the observation period, suggesting the absence of systemic toxicity associated with the topical use of ASD fraction 3 ointment. In conclusion, topical application of ASD fraction 3 ointment was associated with favorable wound healing dynamics, controlled inflammatory response, maintenance of metabolic balance, and no detectable adverse systemic effects. These findings suggest that ASD-based topical therapy may represent a promising adjunctive option for wound management in cats, warranting further controlled and comparative studies.


  • Open Access

    The role of melatonin in the regulation of the immune system and reproductive health: mechanisms and prospects for clinical application

    by M. M. Zhelavskyi, S. P. Kernychnyi, O. Ya. Dmytriv, T. V. Betlinska

    Melatonin is a multifunctional hormone with diverse physiological roles, particularly in immune regulation and reproductive health. While primarily synthesized by the pineal gland in response to the circadian rhythm, melatonin is also produced in extrapineal tissues such as the placenta, gastrointestinal tract, and reproductive organs, highlighting its systemic significance. Beyond its role in sleep-wake cycle regulation, melatonin exhibits potent antioxidant, anti-inflammatory, and immunomodulatory properties, making it essential for maintaining cellular homeostasis and overall physiological stability. In the immune system, melatonin contributes to both innate and adaptive immunity by modulating cytokine production, reducing oxidative stress, and enhancing immune cell activity. It plays a protective role against infections and inflammatory diseases by suppressing pro-inflammatory mediators such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) while promoting anti-inflammatory cytokines like interleukin-10 (IL-10). Additionally, melatonin influences immune tolerance, which is critical for preventing autoimmune responses and ensuring successful pregnancy. In females, melatonin improves oocyte quality, embryo development, and pregnancy outcomes by protecting ovarian follicles from oxidative damage, regulating steroidogenesis, and supporting placental function. Its role in fetal development is particularly significant, as it contributes to maternal-fetal circadian signaling, placental vascularization, and epigenetic modifications that influence gene expression. In men, melatonin contributes to spermatogenesis and improves sperm quality by boosting mitochondrial activity, decreasing oxidative stress, and safeguarding sperm DNA from damage. Additionally, it helps regulate hormone production in the testes, maintaining optimal reproductive health. Given its pleiotropic effects, melatonin holds substantial therapeutic potential for addressing immune dysfunction, reproductive disorders, and pregnancy complications. Future research should focus on clinical applications of melatonin supplementation in treating infertility, pregnancy-related complications, and immune-mediated diseases. Understanding the intricate relationship between melatonin, immunity, and reproduction may pave the way for innovative therapeutic strategies in both human and veterinary medicine. Melatonin is a multifunctional hormone with essential roles in immune regulation and reproductive health. Beyond its well-known function in circadian rhythm regulation, melatonin exerts potent antioxidant, anti-inflammatory, and immunomodulatory effects. It plays a critical role in maintaining immune homeostasis by reducing oxidative stress, modulating cytokine production, and enhancing immune cell function, thereby offering protection against infections and inflammatory disorders. In reproduction, melatonin influences key processes such as oocyte maturation, embryo development, and pregnancy maintenance. It supports fertility by improving ovarian function, regulating gonadotropin secretion, and protecting reproductive tissues from oxidative damage. Additionally, melatonin's involvement in placental function and fetal development highlights its significance in ensuring successful gestation. Given its widespread physiological effects, melatonin presents promising therapeutic potential for addressing immune-related and reproductive disorders. Future research exploring its clinical applications may lead to novel strategies for enhancing reproductive success and immune resilience in both human and veterinary medicine.


  • Canine Mast Cell Tumors: Clinical Signs, Laboratory Diagnosis, Treatment, and Prognosis

    by Mykola Zhelavskyi, Serhii Kernychnyi, Tatiana Zakharova, Tamara Betlinska, Maksym Luchkа

    Canine mast cell tumors, a tumor originating from mast cells involved in allergic reactions and inflammation, are among the most common skin tumors in dogs. The present study aimed to explore the clinical features, diagnostic approaches, and prognosis of canine mastocytomas through a case study. A 5-year-old male Akita, weighing 35.8 kg, was brought to the Doctor VET veterinary clinic in Kamianets-Podilskyi, Ukraine, for evaluation. Upon initial examination, the dog had a body temperature of 38.5°C, a heart rate of 74 beats per minute (bpm), and a respiratory rate of 28 breaths per minute, all of which were within normal physiological limits. The animal was alert and responsive and displayed no signs of systemic distress. A detailed physical examination revealed a tumor located 35.2 mm below the plantar surface of the tarsal joint (art. tarsi). The tumor was round, mobile, and surrounded by a thin fibrous capsule, with no signs of pain or discomfort during palpation. Cytological analysis showed a high-cellularity smear with numerous mast cells scattered throughout the field. These cells were round to oval in shape with abundant cytoplasm containing dense, basophilic to metachromatic granules. The hematological evaluation indicated a systemic inflammatory or immune response triggered by the tumor, as evidenced by neutrophilic leukocytosis (73.1%; 8.89×10⁹/L). Biochemical analysis revealed an elevated alkaline phosphatase activity level (4.45 μmol/L), suggesting systemic involvement. The tumor was surgically excised, ensuring complete removal with wide margins to minimize the risk of recurrence. Histological examination of the excised tissues confirmed a densely cellular neoplastic infiltrate composed predominantly of mast cells arranged in sheets and clusters. The mast cells displayed significant cellular and nuclear pleomorphism, characterized by moderate to marked anisocytosis and anisokaryosis. While no significant necrosis was observed, scattered apoptotic bodies were present, indicating ongoing cellular turnover. This case highlighted the critical importance of early diagnosis and comprehensive management of canine mastocytomas. Low-grade tumors often carry a favorable prognosis when treated promptly and appropriately. However, higher-grade or poorly differentiated tumors may require multimodal therapeutic approaches to achieve better outcomes.


  • Fertility Restoration in Progestogen-Treated Hungarian Wirehaired Vizslas: Effects of GnRH Agonist on Reproductive Activity

    by Mykola Zhelavskyi, Serhii Kernychnyi, Valerii Tsvilikhovskyi, Volodymyr Mizyk, Tamara Betlinska, Maksym Luchkа

    Deslorelin implants are increasingly utilized in veterinary reproductive management as a reversible alternative to surgical sterilization in dogs. The present study evaluated the biphasic response to deslorelin (Suprelorin®, 4.7 mg; Virbac®, France) in Hungarian Wirehaired Vizsla bitches after long-term progestogen-induced estrus suppression and assessed its efficacy for estrus induction and hormonal response sterilization. Thirty healthy bitches, aged 2-3 years and weighing from 19.8 to 23.7 kg, were enrolled in the study, which was divided into three groups, including a control group (C1) and two experimental groups (E1 and E2), each comprising 10 bitches. All of these dogs received subcutaneous deslorelin implants during anestrus. In E1, bitches previously treated with medroxyprogesterone acetate for 18 to 24 months received the implant for estrus induction, which was surgically removed on day 7. In E2, the implant was used for prolonged estrus suppression. Cytology and hormone analysis samples (progesterone, luteinizing hormone) were collected from the cephalic vein at specific time points; during anestrus (day 160), before implantation in controls, proestrus (day 3), estrus (days 1-3), the flare-up phase (72 hours post-implantation), and post-removal (day 7, group E1). Diestrus was monitored on days 7, 9, 11, 14, 15, 30, and 60 for the E2 group under suppression. Cytological assessment was performed using Diff-Quik™ staining, and hormone levels were measured via chemiluminescent immunoassay and ELISA. Ultrasonography and physical examination were used to monitor reproductive tract status. The present study confirmed a biphasic response to deslorelin, characterized by an initial flare-up phase, during which luteinizing hormone (LH) levels and estrous behavior were elevated, peaking on days 3 or 4, followed by effective suppression from day 14 through day 60. Implant removal in group E1 successfully induced fertile estrus, demonstrating Suprelorin's utility for fertility restoration in progestogen-treated bitches. In group E2, the implant provided sustained reproductive suppression for up to 12 months without adverse effects. These results highlighted the dual role of deslorelin in inducing or suppressing estrus, providing a valuable, evidence-based pharmacological option for managing canine reproduction.

  • Open Access

    Luteal insufficiency in canines: Assessment of progesterone dynamics and efficacy of combined hormonal treatment

    by Mykola Zhelavskyi, Mykola Maryniuk, Maryna Drobot, Vitalii Kostenko, Nataliia Boiko, Tetiana Paliukh

    Background: Progesterone, primarily produced by the corpus luteum, is essential for maintaining pregnancy in dogs by promoting endometrial receptivity and supporting fetal development. Hypoluteoidism, defined by inadequate progesterone production, significantly increases the risk of pregnancy loss and reproductive failure. This study evaluates the role of progesterone in canine pregnancy, the risks associated with hormonal deficiency, and the effectiveness of therapeutic intervention. Aim: This study emphasizes the role of progesterone supplementation combined with magnesium and tocopherol in supporting pregnancy maintenance and restoring hormonal homeostasis. Methods: Progesterone levels were monitored across the estrous cycle in French Bulldog bitches (n=20). The control group was divided into two subsets. At the first stage of the study, control group C1 (n=10) consisted of dogs in the anestrus phase. At the second stage, control group C2 (n=10) included dogs on days 18 to 22 of pregnancy. Animals in both control groups (C1 and C2) did not receive any pharmacological treatments throughout the experiment. The experimental group (dogs with luteal insufficiency, days 18 to 22 of pregnancy; n=10) exhibited significantly lower serum progesterone levels (9.90 ± 0.19 nmol/L) compared to the control group (55.60 ± 2.23 nmol/L, p<0.001). Serum progesterone levels were measured using the Immulite® system (Siemens Healthcare Diagnostics GmbH, Eschborn, Germany). The experimental group received treatment with exogenous progesterone (medroxyprogesterone acetate, MPA, Perlutex® 5 mg, Dechra, UK), administered orally at a dose of 0.1 mg/kg/day. The treatment was combined with tocopherol acetate (2.0 ml, 500 IU) for 21 days and MagiCalm® (1 tablet per 10–25 kg/day for 10–12 days). Blood sampling for hematological and hormonal analysis was conducted as follows: for the control group - on days 18–22 of gestation. In the experimental group (luteal insufficiency), samples were collected on the day treatment was initiated (Day 0; gestational days 18–22, prior to treatment initiation), and subsequently on treatment days 5 (23–27 days - 20.03±0.75 nmol/L; p < 0.001 ), 10 (33-37 days - 37.76±0.40 nmol/L; p < 0.001), 20 (43-47 days - 43.25±0.57 nmol/L; p < 0.001), and 30 (53-57 days - 33.37±0.87; p < 0.001). Results: It was found that during the anestrus phase (control group C1), the progesterone concentration was minimal (1.53 ± 0.07 nmol/L). Progesterone levels showed significant variation across different phases of the estrous cycle, measuring 4.56 ± 0.20 nmol/L (p < 0.001) in proestrus, 19.54 ± 0.17 nmol/L in estrus (p < 0.001), and peaking at 37.61 ± 1.96 nmol/L (p < 0.001) in metestrus. On gestational days 18–22, healthy bitches in control group C2 exhibited a plasma progesterone concentration of 55.60 ± 2.23 nmol/L, indicating normal luteal function. In contrast, the experimental group (bitches with luteal insufficiency on days 18–22 of gestation) demonstrated a significant decrease in progesterone levels (9.95 ± 0.27 nmol/L; p<0.001), accompanied by clinical signs such as restlessness, dark red vaginal discharge, and increased abdominal muscle tone. Throughout the treatment period, no critical clinical symptoms indicative of pregnancy loss were observed in animals with luteal deficiency. The clinical condition of all patients remained satisfactory. The pregnancies progressed with a dynamic normalization of plasma progesterone levels and culminated in normal, complication-free parturition. Conclusion: Progesterone therapy, when combined with tocopherol and magnesium, effectively addresses luteal insufficiency in dogs, improving implantation success rates and reducing pregnancy loss. This study highlights the importance of progesterone in canine reproduction and supports its supplementation as a viable treatment for hormonal imbalances.


  • Sebaceous Adenitis in an Akita: Symptoms and Therapeutic Approaches

    by Mykola Zhelavskyi, Mykola Maryniuk, Maryna Drobot

    Sebaceous adenitis is observed in different animal species, with dogs being the most commonly diagnosed. This study aimed to report a case of sebaceous adenitis in a 5-year-old male Akita dog weighing 35.8 kg, initially presented with pruritus and alopecia on the inner ear surfaces, face, and head. Over time, signs of changes in sebaceous glands appeared in other body parts. The dog was sent to a veterinary clinic in Kamyanets-Podilsky, Ukraine. During the clinical examination, the body temperature was 38.4°C, heart rate 78 bpm, and a respiratory rate 27 breaths per minute, with no change in appetite. Clinical and dermatological methods and histopathological examination were used to detect the disease. The hair on the head was curling, and the lesions appeared on the dorsal tail, the distal front and hind legs, the groin, and the abdomen. Initially, redness and itching occurred in the affected areas, and the skin lost elasticity and became dry. The hair was stuck together with gray crusts. The diagnosis was confirmed based on pathohistological studies. An inflammatory infiltrate with migration of lymphocytes, histiocytes, neutrophils, and atrophy of sebaceous glands was diagnosed, focusing on the pathology of the dermis. Treatment included topical therapy with shampoo applied for 3-5 minutes, then rinsed and followed by Conditioner for 2 minutes, over 30 days. Omega-3 was administered orally at 1000 mg twice daily. Isotretinoin (Roaccutane®, 20 mg) was administered orally twice daily for 30 days. Moreover, Cyclosporine was dosed at 5 mg/kg once daily orally, on an empty stomach, for 30 days. During the treatment, signs of inflammation gradually disappeared, with itching and hyperemia disappearing from day 3. From day 7, desquamation and hair loss decreased, and on day 12, signs of new hair growth appeared. The areas were completely restored on day 28 of treatment. Sebaceous adenitis was found to lead to the destruction of sebaceous glands, causing scaling, hair loss, and skin inflammation, which could be a hereditary condition in Akitas. Immunomodulation and normalization of trophic processes in the skin are crucial in the treatment.


  • Open Access

    Isomaltose in cattle feeding: biochemical processes and prevention of metabolic changes

    by Yu. M. Butkalyuk, M. M. Zhelavskyi

    The article discusses the role of isomaltose as an important component of the diet for cattle (bovine), focusing on its impact on energy balance, prevention of metabolic disorders, and overall animal health. The authors emphasize that issues such as ketosis and acidosis pose serious threats to milk production, as they can negatively affect productivity and animal welfare. Isomaltose, being a disaccharide, is quickly broken down into glucose, making it an effective source of rapid energy, especially during periods of increased energy demands, such as lactation. This not only supports energy balance but also significantly reduces the risk of developing ketosis, as the organism has a stable supply of energy from glucose. In addition to its energy benefits, isomaltose possesses prebiotic properties that promote the growth of beneficial bacteria in the rumen. This improves the microbiological composition of the flora and enhances feed digestion efficiency, which, in turn, contributes to the production of short-chain fatty acids (SCFAs) during fermentation. The production of SCFAs helps maintain stable pH levels in the rumen, which is critical for preventing acidosis. The conclusions of the article highlight that isomaltose is an effective source of rapid energy that helps maintain milk productivity and overall animal health. Including isomaltose in the diet can significantly reduce the risks of metabolic disorders by ensuring a stable energy balance and supporting a healthy rumen microbiota. The authors also provide practical recommendations for farmers regarding diet optimization, emphasizing the importance of including isomaltose to enhance production efficiency and animal welfare. Overall, isomaltose represents a valuable feed additive capable of significantly improving milk production outcomes and animal health.

  • APOPTOSIS OF NEUTROPHILS, MONOCYTES, AND LYMPHOCYTES IN THE PERIPHERAL BLOOD OF COWS DURING LACTATION

    by Mykola Zhelavskyi

    The immune system of animals plays an important role in the homeostasis system. This aimed at the apoptosis of immune cells of the peripheral bloodstream and milk secretions at different periods of lactation in cows. The investigation of the immune defense of cows was conducted during various lactation periods: early (3-5 days), mid (90-150 days), and late (drying off - 5-7 days; dry period - 12-20 days) periods of mammary gland function. The highest intensity of apoptosis neutrophils (P<0.01) and monocytes (P<0.01) in the mid-lactation period. The highest intensity of apoptosis is observed in phagocytic cells during the secretions colostrum period and mammary gland involution. The study of physiological constants of blood cell apoptosis will serve as a basis for developing informative methods of mastitis diagnosis in cows and implementing effective treatment measures. The findings obtained from this research are valuable for practical veterinarians and from a public health perspective.


  • The Role of Neutrophils and NETosis in Local Immunity of Feline Inflammatory Aural Polyps

    by Mykola Zhelavskyi, Mykola Maryniuk, Maryna Drobot

    Feline inflammatory aural polyps are abnormal growths that can occur in the ear canals of cats, particularly in the middle ear. These polyps are frequently linked to persistent inflammation and can result in a range of ear-related complicated pathologies. The etiology is multifactorial. The purpose of the research was to study the cytology of an inflammatory polyp in a cat and to study the role of neutrophils and their mechanisms on the formation of extracellular protective traps by neutrophils (NETs). A 4-year-old, female spayed, Scottish fold cat, weighing 3.5 kg sent to a veterinary clinic (Mirra-Vet, Kyiv, Ukraine). Clinical, otoscopic methods, and laboratory methods of cytological diagnostics were used for the research. At the onset of the clinical investigation, exudate discharge from the ear and a painful response were observed. Upon detailed otoscopy, a polyp in the ear canal was diagnosed. An increase in the number of leukocytes (23.2×109/L), their absolute content, and an increase in the percentage of neutrophils (48.2 %) in the leukogram. Assessing the capacity of neutrophils to generate NETs (Neutrophil Extracellular Traps) was determined after samples were collected using a cytologic brush. Cytological analysis of samples from the inter-tragic incisure area highlighted a significant presence of neutrophils, forming extracellular protective traps. The results revealed free NETs in separate areas of the slides. The findings indicated the formation of cooperative groups among neutrophils, other phagocytes, and epithelial cells, along with slender nuclear streaks. During the treatment (Otoflox, 2 drops per ear), the inflammatory reaction disappears, polyp size decreases, exudative reactions decrease, and neutrophil activity decreases. After 3 days of treatment, the animal's condition improved. The ear was clean without sulfur and lesions. The complete treatment course spanned 7 days. During the treatment, the inflammatory reaction disappeared, polyp size decreased, exudative reactions decreased, and neutrophil activity decreased. Experimental studies have shown that during the inflammatory reaction in the ear, protective mechanisms of local immune defense are activated. Activated neutrophils perform their function through phagocytosis and the formation of NETs. These studies contribute to supplementing the data on the immunopathological mechanisms of feline inflammatory polyps.